Skip to main content
. 2022 Sep 18;4:100317. doi: 10.1016/j.puhip.2022.100317

Table 2a.

Biochemical and anthropometric profile of participantsa in the proof-of-concept trial data.

Characteristic(s) Baseline Profile (number of participants = 55)
Age (years) 34.1 ± 5.7
hs-CRP (mg/L) 1.9 (1.0, 3.8)
Triglycerides-to-HDL cholesterol ratio 6.1 ± 2.3
HDL-C (mg/dL) 32.5 ± 3.8
Triglycerides (mg/dL) 196.3 ± 71.7
Total cholesterol (mg/dL) 199.8 ± 34.7
LDL-C (mg/dL) 128.1 ± 30.3
Non-HDL-C (mg/dL) 167.2 ± 34.1
Total cholesterol-to-HDL ratio 6.2 ± 1.2
Weight (kg) 73.9 ± 13.8
BMI (kg/m2) 26.2 ± 3.9
Body fat (%) 25.3 ± 3.8
Tobacco users (%) 7.3

Values are expressed as mean ± SD or median (interquartile range).

aThe proof-of-concept trial was conducted on free-living Indian men, aged 25–44 years, recruited from an urban setting in Delhi-NCR (India), with TG/HDL-ratio≥4.0 and HDL-C<40 mg/dL, and not on treatment for dyslipidemia, diabetes or hypertension.